BEVERLY, Mass.--(BUSINESS WIRE)--INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that management will be presenting at the European Society of Human Reproduction and Embryology (“ESHRE”) annual meeting to be held in Amsterdam, Netherlands on June 28-July 1, 2009, and at the 2009 RedChip Small-Cap Investor Conference to be held on June 16, 2009 in Fort Lauderdale, Fla. INVO Bioscience’s patented product, the INVOcell, allows for vaginal incubation of eggs, sperm and early embryo development during the infertility treatment process.
